Related Experiment Video
Updated: Jul 13, 2026

Functional Mapping with Simultaneous MEG and EEG
Published on: June 14, 2010
Predicting response to tVNS in patients with migraine using functional MRI: A voxels-based machine learning analysis
Chengwei Fu1,2, Yue Zhang1, Yongsong Ye1
1Department of Radiology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
This study identifies brain imaging biomarkers using machine learning to diagnose migraine without aura and predict treatment response to transcutaneous vagus nerve stimulation (tVNS). These biomarkers can help personalize migraine treatment strategies.
Area of Science:
- Neuroimaging
- Neurology
- Machine Learning
Background:
- Migraine diagnosis lacks objective biomarkers, leading to misdiagnosis.
- Transcutaneous vagus nerve stimulation (tVNS) shows variable efficacy in migraineurs.
- Identifying biomarkers is crucial for accurate diagnosis and personalized tVNS treatment.
Purpose of the Study:
- To identify objective biomarkers for diagnosing migraine without aura (MWoA).
- To develop a predictive model for tVNS treatment efficacy in MWoA patients.
- To correlate brain activity patterns with migraine attack frequency reduction.
Main Methods:
- Functional magnetic resonance imaging (fMRI) was used to analyze fractional amplitude of low-frequency fluctuation (fALFF) in 70 MWoA patients and 70 controls.
- Support vector machine (SVM) and support vector regression (SVR) were employed for biomarker identification and prediction.
- Brain regions including the trigeminal cervical complex/rostral ventromedial medulla (TCC/RVM), thalamus, medial prefrontal cortex (mPFC), and temporal gyrus were analyzed.
Main Results:
- A biomarker with 3,650 features accurately discriminated MWoA patients (79.3% accuracy).
- Key discriminative regions included TCC/RVM, thalamus, mPFC, and temporal gyrus.
- A predictive model using 70 features showed a correlation coefficient of 0.36 for predicting tVNS efficacy.
Conclusions:
- Machine learning identified potential biomarkers for MWoA diagnosis and tVNS response prediction.
- Pivotal features were located in TCC/RVM, thalamus, mPFC, and temporal gyrus.
- These findings support the use of neuroimaging biomarkers for personalized migraine management.
More Related Videos
09:36Extracting Visual Evoked Potentials from EEG Data Recorded During fMRI-guided Transcranial Magnetic Stimulation
Published on: May 12, 2014
08:23A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016